23.4% Below Target

The consensus Wall Street price target for XOM is $170.08, representing 23.4% upside from the current price of $137.81. With 55 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

XOM has a consensus rating of "Hold" based on 55 Wall Street analysts. The rating breakdown is mixed, with 26 Hold ratings making up the largest segment. The consensus 12-month price target of $170.08 implies 23.4% upside from current levels.

With a forward P/E of 12.547x, XOM trades at a relatively low valuation. The consensus target of $170.08 implies 23.4% appreciation, suggesting meaningful undervaluation.

The most bullish Wall Street analyst has a price target of $185 for XOM, while the most conservative target is $123. The consensus of $170.08 represents the median expectation. Our quantitative valuation model projects a bull case target of $243 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

XOM is heavily covered by Wall Street, with 55 analysts providing price targets and ratings. Of these, 1 have Strong Buy ratings, 23 have Buy ratings, 26 recommend Hold, and 5 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month XOM stock forecast based on 55 Wall Street analysts shows a consensus price target of $170.08, with estimates ranging from $123 (bear case) to $185 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $184, with bear/bull scenarios of $116/$243.

Our quantitative valuation model calculates XOM's fair value at $184 (base case), with a bear case of $116 and bull case of $243. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 46/100.

XOM trades at a forward P/E ratio of 12.5x based on next-twelve-months earnings estimates compared to a trailing P/E of 20.6x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Wall Street analysts are very optimistic on XOM, with a "Hold" consensus rating and $170.08 price target (23.4% upside). 24 of 55 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

XOM analyst price targets range from $123 to $185, a 36% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $170.08 consensus represents the middle ground. Our model's $116-$243 range provides an independent fundamental perspective.